Top Michigan Biotech Startups (35)
Hummingbird Bioscience is a data-driven precision biotherapeutics team discovering and developing transformative biologic medicines for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology, and wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. We harness this integrated approach across target identification and patient selection, enabling our team to increase the efficiency...
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with...
Arbor Assays specializes in the development of high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. We also offer custom assay development and testing services. We make unique kits to measure cGAMP,...
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once.
Allozymes is a leading deep technology company that applies its proprietary microfluidics technology to develop custom-designed enzymes for cleaner and sustainable manufacturing of complex natural products. Allozymes’ interdisciplinary innovation enables 10x faster enzyme engineering with a 200X higher chance of success compared to robotics which enables breakthrough development in a wide range of industries.
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
Akadeum Life Sciences, an emerging life science startup, is located in Ann Arbor, MI. Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached. At Akadeum, we strive to disrupt the status quo by delivering a technology that can isolate any sample, any volume, anywhere.
The Life Sciences business of Truven Health Analytics (www.truvenhealth.com/life-sciences) is a trusted, full service market access, stakeholder management, and health economics and outcomes research (HEOR) consultancy serving the global pharmaceutical, medical device and biotech industry. With the 2014 acquisition of Heartbeat Experts (www.heartbeatexperts.com) into our Life Sciences business, we offer the leading KOL and market access stakeholder identification, profiling, mapping...
Forever Labs banks your stem cells to help you live healthier, longer.
Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
Everist Health is a medicine company developing technologies focused on cancer, cardiovascular diseases and diabetes.
Phrixus Pharmaceuticals develops and commercializes heart failure-related pharmaceutical products and therapies.
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation.
OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
